System and method for identification and verification of authorization of a subject to use a substance delivery device.

Cartridges for use in vaporizer or vaporization devices are disclosed herein. Vaporizer or vaporization devices, atomizer components, and methods are also disclosed herein.

A fiber reinforced polyester polymer composition is disclosed that contains at least one tribological modifier. The tribological modifier may comprise an ultra-high molecular weight silicone alone or in combination with polyytetrafluoroethylene particles. The composition not only has excellent tensile properties but also can produce a low friction surface.

A personal vapor inhaling unit is disclosed. An electronic flameless vapor inhaler unit that may simulate a cigarette has a cavity that receives a cartridge in the distal end of the inhaler unit. The cartridge brings a substance to be vaporized in contact with a wick. When the unit is activated, and the user provides suction, the substance to be vaporized is drawn out of the cartridge, through the wick, and is atomized by the wick into a cavity containing a heating element. The heating element vaporizes the atomized substance. The vapors then continue to be pulled by the user through a mouthpiece and mouthpiece cover where they may be inhaled.

There is provided an inhalation device for delivering a deliverable agent in the form of an aerosol or vapour to a user. The device comprises a solid, porous carrier material having a defined porosity, and a deliverable agent located within the pores of the carrier material. The device is operable to heat the carrier material and vaporise the deliverable agent. Deliverable agents that may be delivered to the user include active pharmaceutical ingredients. Suitable materials for the porous carrier material include chemically bonded ceramic materials and geopolymeric materials.

A dose unit including at least one isolated bioactive agent applied on a carrier material in thermal contact with an electrically heating element configured to vaporize a pre-determined amount of the agent for pulmonary delivery thereof is provided herein, as well as devices for effecting vaporization and pulmonary delivery of the isolated agent, and methods for preparing the dose unit, controllably releasing the agent therefrom, methods for pulmonary delivery thereof and methods of treatment of medical conditions treatable by pulmonary delivery of the isolated bioactive agent.

Embodiments of the disclosure include a removable face mask enhancing insert comprising an absorbent material; an adhesive applied to a first side of the absorbent material; and a solution applied to at least a second side of the absorbent material, wherein the solution is configured to evaporate from the absorbent material.

According to an aspect, there is provided a training device for use in an inhaler, the training device comprising a body that is configured to be received at a first position in a housing of an inhaler, wherein the body comprises an interface arranged to connect to a canister interface in the housing of the inhaler; an electrical circuit configured to perform one or more functions; and a circuit triggering mechanism that comprises a switch for enabling the electrical circuit to perform the one or more functions when the switch is closed, wherein the circuit triggering mechanism is configured such that the switch is closed when the body is pressed from the first position towards the canister interface and into a second position in the housing of the inhaler.

Provided is a system comprising an inhaler. The inhaler comprises a use determination system. The use determination system is configured to determine at least one first value of a usage parameter relating to use of the inhaler. A processing module is configured to receive the at least one first value. The processing module is also configured to receive a second value indicative of whether the subject is also suffering from a viral respiratory infection. The processing module then determines the level of acute risk based on the at least one first value and the second value. Also provided is a system for determining a probability that a subject having a chronic respiratory disease also has a severe acute respiratory syndrome. The system comprises a first inhaler for delivering a rescue medicament prescribed for the chronic respiratory disease. The first inhaler has a use determination system configured to determine a rescue inhalation performed by the subject using the first inhaler. The system optionally includes a second inhaler for delivering a maintenance medicament to the subject during a routine inhalation A sensor system is configured to measure a parameter relating to airflow during the rescue inhalation and/or during the routine inhalation, when the second inhaler is included in the system. The system further comprises a processor configured to determine a number of the rescue inhalations during a first time period, and receive the parameter measured for at least some of the rescue and/or routine inhalations. The processor then determines the probability of the subject having the severe acute respiratory syndrome based on the number of rescue inhalations and the parameters. Further provided is a method for determining the probability of an asthma exacerbation in a subject, which method employs the weighted model.

A device for inhaling powdery substances contained in capsules has a housing, a capsule receiver, a closing cover, a mouth piece, and a closure cap. The closure cap is designed to cover simultaneously the mouthpiece, closing cover and capsule receiver, wherein the closure cap, mouthpiece and closing cover are hinged in a pivoting manner. Two pivot axes, which are different but run in the same direction, are formed, which, in respect of a side view in which geometric axes of the pivot axes are represented in the form of points, are arranged next to each other and on a same side of the capsule receiver. In a usage state of the device, the first pivot axis is arranged closer to the capsule receiver. The closing cover and the mouthpiece can be pivoted about the first pivot axis and only the closure cap can be pivoted about the second pivot axis.